Logo image of SRE

SEMPRA (SRE) Stock Fundamental Analysis

NYSE:SRE - New York Stock Exchange, Inc. - US8168511090 - Common Stock - Currency: USD

78.23  -0.2 (-0.26%)

After market: 78.23 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SRE. SRE was compared to 25 industry peers in the Multi-Utilities industry. SRE has a medium profitability rating, but doesn't score so well on its financial health evaluation. SRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SRE had positive earnings in the past year.
In the past year SRE had a positive cash flow from operations.
SRE had positive earnings in each of the past 5 years.
Each year in the past 5 years SRE had a positive operating cash flow.
SRE Yearly Net Income VS EBIT VS OCF VS FCFSRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.95%, SRE is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
The Return On Equity of SRE (9.23%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.83%, SRE is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for SRE is in line with the industry average of 3.83%.
Industry RankSector Rank
ROA 2.95%
ROE 9.23%
ROIC 2.83%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SRE Yearly ROA, ROE, ROICSRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 21.89%, SRE belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
SRE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 22.65%, SRE is in the better half of the industry, outperforming 64.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SRE has declined.
Industry RankSector Rank
OM 22.65%
PM (TTM) 21.89%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SRE Yearly Profit, Operating, Gross MarginsSRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

SRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SRE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SRE has more shares outstanding
The debt/assets ratio for SRE is higher compared to a year ago.
SRE Yearly Shares OutstandingSRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SRE Yearly Total Debt VS Total AssetsSRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

A Debt/Equity ratio of 1.12 is on the high side and indicates that SRE has dependencies on debt financing.
SRE has a better Debt to Equity ratio (1.12) than 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.42
WACC6.71%
SRE Yearly LT Debt VS Equity VS FCFSRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SRE has a Current Ratio of 0.57. This is a bad value and indicates that SRE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.57, SRE is doing worse than 92.00% of the companies in the same industry.
SRE has a Quick Ratio of 0.57. This is a bad value and indicates that SRE is not financially healthy enough and could expect problems in meeting its short term obligations.
SRE has a worse Quick ratio (0.51) than 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.51
SRE Yearly Current Assets VS Current LiabilitesSRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.12% over the past year.
SRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.31% yearly.
Looking at the last year, SRE shows a decrease in Revenue. The Revenue has decreased by -3.28% in the last year.
The Revenue has been growing slightly by 4.04% on average over the past years.
EPS 1Y (TTM)5.12%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%7.46%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%4.45%

3.2 Future

The Earnings Per Share is expected to grow by 6.58% on average over the next years.
Based on estimates for the next years, SRE will show a small growth in Revenue. The Revenue will grow by 2.19% on average per year.
EPS Next Y-1.08%
EPS Next 2Y4.66%
EPS Next 3Y5.64%
EPS Next 5Y6.58%
Revenue Next Year-4.86%
Revenue Next 2Y-0.24%
Revenue Next 3Y1.02%
Revenue Next 5Y2.19%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRE Yearly Revenue VS EstimatesSRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SRE Yearly EPS VS EstimatesSRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.57, the valuation of SRE can be described as correct.
SRE's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.60, SRE is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.46, SRE is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRE is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.43. SRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.57
Fwd PE 15.46
SRE Price Earnings VS Forward Price EarningsSRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

88.00% of the companies in the same industry are cheaper than SRE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.55
SRE Per share dataSRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.66%
EPS Next 3Y5.64%

More info and screens

5

5. Dividend

5.1 Amount

SRE has a Yearly Dividend Yield of 3.37%. Purely for dividend investing, there may be better candidates out there.
SRE's Dividend Yield is comparable with the industry average which is at 3.67.
Compared to an average S&P500 Dividend Yield of 2.36, SRE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

The dividend of SRE decreases each year by -9.71%.
SRE has paid a dividend for at least 10 years, which is a reliable track record.
As SRE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-9.71%
Div Incr Years7
Div Non Decr Years7
SRE Yearly Dividends per shareSRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

SRE pays out 53.42% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.42%
EPS Next 2Y4.66%
EPS Next 3Y5.64%
SRE Yearly Income VS Free CF VS DividendSRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SRE Dividend Payout.SRE Dividend Payout, showing the Payout Ratio.SRE Dividend Payout.PayoutRetained Earnings

More info and screens

SEMPRA

NYSE:SRE (5/20/2025, 8:04:00 PM)

After market: 78.23 0 (0%)

78.23

-0.2 (-0.26%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners93.92%
Inst Owner Change-0.75%
Ins Owners0.03%
Ins Owner Change14.24%
Market Cap51.00B
Analysts74.78
Price Target81.26 (3.87%)
Short Float %1.14%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP53.42%
Div Incr Years7
Div Non Decr Years7
Ex-Date03-20 2025-03-20 (0.645)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.43%
Min EPS beat(2)-7.18%
Max EPS beat(2)8.03%
EPS beat(4)1
Avg EPS beat(4)-5.36%
Min EPS beat(4)-16.27%
Max EPS beat(4)8.03%
EPS beat(8)4
Avg EPS beat(8)-1.23%
EPS beat(12)8
Avg EPS beat(12)2.43%
EPS beat(16)11
Avg EPS beat(16)2.54%
Revenue beat(2)0
Avg Revenue beat(2)-9.28%
Min Revenue beat(2)-14.67%
Max Revenue beat(2)-3.89%
Revenue beat(4)0
Avg Revenue beat(4)-13.33%
Min Revenue beat(4)-22.35%
Max Revenue beat(4)-3.89%
Revenue beat(8)0
Avg Revenue beat(8)-15.32%
Revenue beat(12)3
Avg Revenue beat(12)-3.67%
Revenue beat(16)7
Avg Revenue beat(16)-0.69%
PT rev (1m)-3.6%
PT rev (3m)-15.68%
EPS NQ rev (1m)8.68%
EPS NQ rev (3m)-6.87%
EPS NY rev (1m)0.11%
EPS NY rev (3m)-12.14%
Revenue NQ rev (1m)-2.95%
Revenue NQ rev (3m)-2.89%
Revenue NY rev (1m)-2.83%
Revenue NY rev (3m)-10.43%
Valuation
Industry RankSector Rank
PE 16.57
Fwd PE 15.46
P/S 3.82
P/FCF N/A
P/OCF 11.24
P/B 1.61
P/tB 1.71
EV/EBITDA 15.55
EPS(TTM)4.72
EY6.03%
EPS(NY)5.06
Fwd EY6.47%
FCF(TTM)-7.77
FCFYN/A
OCF(TTM)6.96
OCFY8.9%
SpS20.47
BVpS48.57
TBVpS45.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.95%
ROE 9.23%
ROCE 3.39%
ROIC 2.83%
ROICexc 2.89%
ROICexgc 2.95%
OM 22.65%
PM (TTM) 21.89%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexcg growth 3Y-8.37%
ROICexcg growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Debt/EBITDA 6.48
Cap/Depr 394.01%
Cap/Sales 71.94%
Interest Coverage 250
Cash Conversion 83.11%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.51
Altman-Z N/A
F-Score4
WACC6.71%
ROIC/WACC0.42
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.12%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%7.46%
EPS Next Y-1.08%
EPS Next 2Y4.66%
EPS Next 3Y5.64%
EPS Next 5Y6.58%
Revenue 1Y (TTM)-3.28%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%4.45%
Revenue Next Year-4.86%
Revenue Next 2Y-0.24%
Revenue Next 3Y1.02%
Revenue Next 5Y2.19%
EBIT growth 1Y1.34%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year63.85%
EBIT Next 3Y22.01%
EBIT Next 5Y14.31%
FCF growth 1Y0.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y199.54%
OCF growth 3Y8.5%
OCF growth 5Y9.71%